Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dow Corning was a global leader in silicone and silicon-based technologies with a significant presence in healthcare and medical devices. It developed over-the-counter topical ingredients for scar, stretch mark, acne treatments, and provided silicone materials for implantable devices such as breast implants. The company was acquired by The Dow Chemical Company in June 2016; its operations now continue under the name "Dow Silicones Corporation" as part of Dow[2][7].
Clinical results are not directly applicable since the company primarily supplied materials/ingredients rather than developing finished therapeutics.
Notably, its silicone breast implant materials were used in pioneering reconstructive/cosmetic surgery applications[1].
Its topical ingredient portfolio includes more than a dozen solutions designed to meet regulatory requirements for healthcare applications[6].
Hemlock Semiconductor remains a major subsidiary focused on high-purity silicon production[2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dow Corning.